Improvement in Survival in Patients With Advanced Non-small Cell Lung Cancer
Patients with advanced NSCLC have improved prognoses in the last 20 years except for patients with pulmonary fibrosis. To improve the prognosis of patients with lung cancer and pulmonary fibrosis, new strategies and treatments should be developed.
Authors
- Kotaro Yoshida (ORCID: https://orcid.org/0000-0002-8398-0969)
- Hideyuki Takeshima (ORCID: https://orcid.org/0000-0002-8552-2427)
- Toshio Sakatani
- Hiroaki Ikushima (ORCID: https://orcid.org/0000-0002-7053-2841)
- Taku Nishimura (ORCID: https://orcid.org/0000-0002-9011-9245)
- Kaoru Watanabe
- Kazuhiro Usui (ORCID: https://orcid.org/0000-0002-4492-9327)
- Sayaka Ohara (ORCID: https://orcid.org/0000-0003-2691-9587)
Institutions
- NTT Medical Center (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2024-12-30
- DOI
- https://doi.org/10.21873/anticanres.17417
- Citations
- 2
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.84